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Dear Editor
Aberrant Cytokine Responses to
Influenza A Virus in a Child with
Severe Influenza A Infections
Influenza is a common respiratory virus infection. Al-
though it causes significant morbidity, clinical
courses of the infection are self-limited in most cases.
However, the influenza viruses sometimes cause se-
vere and lethal diseases such as acute respiratory dis-
tress syndrome, encephalopathy, and myocarditis.
These severe infections usually occur in patients who
had been apparently healthy and immunocompetent
before infection, and underlying mechanisms for se-
verity are often obscure. We describe a case of 9 year
old boy with repeated severe influenza A infections in
whom aberrant lymphocyte responses to influenza
antigens in vitro were observed.
He had been healthy except for egg allergy out-
grown by age of 2 with no history of severe infections
before the episodes of severe influenza. At age of 6,
he was infected with influenza AH3N2 resulted in
acute respiratory distress syndrome and brain edema
within 24 hours of onset. With methylprednisolone
pulse therapy he recovered without sequelae. He had
second severe influenza AH1N1 infection leading to
lobar pneumonia with severe hypoxemia at age of 9.
Again, he could recover with an intensive care. At the
time of discharge, eosinophilia (34%) was noted with-
out symptoms.
He had been vaccinated with diphtheria, pertussis,
tetanus (DPT), BCG, polio, Japanese encephalitis, ru-
bella, and measles without complications. He had
natural varicella infection without complication. How-
ever, he had large topical vesicles at injected region
following first vaccination against influenza at 5 years
of age. This vaccine was trivalent inactivated influ-
enza HA vaccine. Since then he stopped to receive in-
fluenza vaccinations. He had no previous history of
influenza infection.
At 6 months after his second influenza virus infec-
tion episode, we tested for general immune compe-
tence and found no significant abnormalities, includ-
ing peripheral blood leukocytes, peripheral blood
mononuclear cell subpopulations, phytohaemagg-
lutinin-stimulated proliferative responses of periph-
eral blood mononuclear cells, NK cell function, se-
rum immunoglobulins, and antibody titers to viruses,
except for high serum IgE (3430 IUml), sensitiza-
tion to house dust mite, and eosinophilia (11%). Fur-
thermore, we examined viral immune responses of
the patient in vitro. We found high proliferative re-
sponses to influenza virus A antigens compared to
age-matched controls. The supernatants of mononu-
clear cells cultured for 48 hours with the 2 strains of
influenza virus A antigen were assayed for a panel of
cytokines and chemokines by a beads array system
(Luminex). As shown in Figure 1, production of inter-
feron (IFN)-γ, interleukin (IL)-17, IL-6 and MIP-1α ap-
peared low and that of IL-2, IL-4 and IL-5 and IL-13 by
the influenza virus A antigens was high compared to
age-matched healthy (n = 1) and mild allergic chil-
dren (n = 3) who had influenza infection in the same
season. In addition, production of IL-1β, IL-7, G-CSF,
GM-CSF, IL-6, IL-8, IL-17, MIG, MIP-1α, MIP-1β,
RANTES, and eotaxin also appeared low compared
with the controls. Proliferative responses and cy-
tokinechemokines productions to measles, rubella,
and varicella were similar between the patient and
controls. Specific IgE levels to the 2 influenza virus A
strains by ELISA were also high in the patient (Table
1). No significant mutations in Toll-like receptor 3, 7,
8, and RIG-I genes were identified.
Hypercytokinemia has been reported to correlate
with severe illness in patients with influenza virus in-
fections.1,2 Conversely, inadequate adaptive immune
responses, or defective cytokine production, that lead
to robust viral replication and apoptotic crisis are also
suggested in severe diseases.3 It is still unclear the
role of cytokines and why some of the patients with
influenza virus infection became severe. We describe
here a case of severe influenza, which may be due to
inadequate Th1 and Th17 cytokine responses and ab-
errantly high Th2 cytokine responses. Although the
source of Th2 cytokines is not known, it could be Th2
cells or basophils stimulated by IgE cross-linking
since the patient had specific IgE to influenza.4 The
presence of specific IgE may also explain the fact that
the patient had severe disease only with influenza in-
fection and immunocompetent to other pathogens
since IgE antibody may suppress protective immune
responses. Our case presents a new type of severe in-
fection, which may hint the unknown pathogenesis.
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Fig.　1　Production of cytokine in response to the infl uenza antigens. Isolated PBMCs and 1 : 190 diluted inactivated infl u-
enza HA vaccine components, namely, A/Solomon islands/2006 (H1N1) at 689 μgHA/ml and A/Hiroshima/2005 (H3N2) at 
1200 μgHA/ml, kindly provided by the Kanonji Institute of the Research Foundation for Microbial Diseases of Osaka Univer-
sity, were incubated in 24 well microplate at 37°C in 5% CO2 for 2 days. The supernatants after 48 hours of incubation were 
tested for 20 cytokines, namely, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IFN-γ, TNF-α and GM-CSF, eotaxin, GRO-α, IP-10, 
MCP-1, RANTES, MCP-2, MCP-3, MIP-1α, MIP-1β, MIG with a beads array system (Luminex Corp., Austin, TX, USA) using 
a multiplex cytokine kit (Invitrogen, Carsbad, CA, USA).
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
20
15
10
5
0
IF
N
-γ
 (
pg
/m
l)
IFN-γ
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
15000
10000
5000
0
IL
-6
 (
pg
/m
l)
IL-17IL-6
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
15000
10000
5000
0
M
IP
-1
α 
(p
g/
m
l)
MIP-1α
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
150
100
50
0
IL
-5
 (
pg
/m
l)
IL-5
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
100
80
60
40
20
0
IL
-1
3 
(p
g/
m
l)
IL-13
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
60
40
20
0
IL
-1
7 
(p
g/
m
l)
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
100
80
60
40
20
0
IL
-2
 (
pg
/m
l)
IL-2
A/
H1
N1
/S
olo
m
on
 2
00
6
A/
H3
N2
/H
iro
sh
im
a 
20
04
30
20
10
0
IL
-4
 (
pg
/m
l)
IL-4
versity of Miyazaki, Miyazaki, Japan
Email: fujisawa@mie−m.hosp.go.jp
Conflict of interest : TF received honoraria from
GlaxoSmithKline and Ono Pharmaceutical, and re-
search funding from GlaxoSmithKline and Pfizer.
The rest of the authors have declared that they have
no conflict of interest.
A Case of Severe Influenza A Infection
Allergology International Vol 61, No3, 2012 www.jsaweb.jp 509
Table　1　IgE antibody titers to infl uenza antigens by ELISA
Subjects
History IgE antibody titer (OD)
Allergy Infl uenza A/Solomon 2006 (H1N1) A/Hiroshima 2004 (H3N2) B/Malaysia 2006
Patient FA + 2.92 3.00 3.03
Control child 1 AR + 2.61 1.52 2.31
Control child 2 none + 0.36 0.21 0.19
Control child 3 AR + 0.22 0.25 0.08
Control child 4 BA + 0.40 0.24 0.64
Control child 5 none + 0.27 0.25 0.41
Infl uenza-specifi c IgE antibodies were measured with ELISA according to a method reported elsewhere.5
FA, food allergy; AR, allergic rhinitis; BA, bronchial asthma.
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